Company intelligence / Profile preview

Treatwell Biotech

Taipei, Taiwan

Ownership: Private
Development stage: Other

Overview

Treatwell Biotech is a biotechnology company focused on the development and application of advanced cell therapies and regenerative medicine. The company specializes in the research of mesenchymal stem cells (MSCs) and stem cell-derived exosomes for the treatment of chronic and degenerative conditions such as osteoarthritis and liver disease. Treatwell Biotech operates research and development facilities aimed at clinical translation and provides specialized cell storage and processing services. Their business model integrates therapeutic development with health management services centered on regenerative technologies.

Therapeutic areas: EndocrinologyGastroenterologyRheumatologyOtherImmunology
Modalities: Cell therapyStem cell therapyExosome-based therapy
Industry: Biotech

Beyond the preview

Go deeper on Treatwell Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Treatwell Biotech.

Explore the full profile